CytoMed Therapeutics Balance Sheet (2021-2025) | GDTC

Balance Sheet Dec2021 Dec2022 Dec2023 Dec2024 Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter) 1.85M1.14M6.66M3.74M1.62M
Cash & Current Investments (Quarter) 1.85M1.14M6.66M3.74M1.62M
Receivables - Net (Quarter) 0.57M0.05M0.82M0.01M1.21M
Receivables - Other (Quarter) 0.02M0.03M0.19M0.38M0.38M
Receivables (Quarter) 0.58M0.08M1.01M0.39M1.59M
Prepaid Assets (Quarter) 0.10M0.03M0.12M
Current Assets (Quarter) 2.42M1.80M7.48M4.51M2.83M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 0.10M0.10M0.21M2.45M2.85M
Long-Term Investments (Quarter) 0.20M0.17M0.14M0.17M0.01M
Intangibles (Quarter) 0.03M0.00M0.01M0.07M0.10M
Goodwill & Intangibles (Quarter) 0.03M0.00M0.01M0.07M0.10M
Non-Current Assets (Quarter) 2.06M1.97M1.68M2.89M3.33M
Assets (Quarter) 4.48M3.77M9.16M7.57M6.16M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 0.16M0.30M0.39M0.33M0.34M
Notes Payables (Quarter) 0.28M0.24M0.03M0.03M0.03M
Payables (Quarter) 0.45M0.54M0.41M0.36M0.37M
Short term Debt (Quarter) 0.28M0.24M0.03M0.03M0.03M
Current Leases (Quarter) 0.01M0.01M0.00M0.01M0.02M
Current Taxes (Quarter) 0.00M483.67
Current Deferred Revenue (Quarter) 0.01M0.00M0.00M0.08M0.14M
Total Current Liabilities (Quarter) 2.16M3.00M0.53M0.46M0.55M
Non-Current Liabilities
Non-Current Debt (Quarter) 0.40M0.34M0.30M0.30M0.28M
Operating Leases (Quarter) 0.01M0.00M0.00M0.02M0.04M
Other Non-Current Liabilities (Quarter) 0.11M0.01M0.02M
Total Non-Current Liabilities (Quarter) 0.41M0.34M0.30M0.31M0.33M
Total Liabilities (Quarter) 2.57M3.34M0.83M0.77M0.87M
Shareholder's Equity
Total Debt (Quarter) 0.68M0.58M0.33M0.32M0.32M
Common Equity (Quarter) 1.91M0.42M8.33M6.80M5.29M
Shareholder's Equity (Quarter) 1.91M0.42M8.33M6.80M5.29M
Liabilities and Shareholders Equity (Quarter) 4.48M3.77M9.16M7.57M6.16M
Retained Earnings (Quarter) -3.73M-5.91M-9.13M-11.16M-14.53M